NEW YORK (GenomeWeb News) – Gen-Probe today said that revenues for the first quarter rose 7 percent year over year as blood-screening revenues increased 12 percent.

The San Diego-based molecular diagnostics firm also announced a deal to be acquired by Hologic for $82.75 per share in cash for a total deal value of $3.7 billion.

Gen-Probe's revenues totaled $153.4 million, up from $143 million a year ago, and beating Wall Street estimates of $150.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.